FDAnews
www.fdanews.com/articles/159375-thermo-fishers-xpect-flu-ab-assay-achieves-fda-clearance-for-novel-avian-influenza-a

Thermo Fisher's Xpect Flu A&B Assay Achieves FDA Clearance for Novel Avian Influenza A

October 2, 2013
Analytical sensitivity data shows Thermo Fisher’s Remel Xpect Flu A&B assay is able to detect cultured avian influenza A virus. Analytical reactivity testing for this novel strain is in line with the FDA reclassification proposal for assessing detection of emerging viruses that could potentially cause a public health emergency.
DeviceSpace